Join SGS to discover how the conduct of human challenge trials can safely assess the value of novel or improved drugs and vaccines much more rapidly and efficiently than field trials.
On Day 1 (September 28), in Session 2, at 2.20pm a lecture will be co-presented with Matthew Memoli on the value of well-designed challenge agents titled: “Developing Wild Type strains of virus for use in Human Challenge Trials.”
About the IABS conference
The theme of this event is "2nd Human Challenge Trials in Vaccine Development". During this year's event IABS is hosting a workshop to review the use of HCTs to promote the development of new drugs and vaccines, the benefits and risks of this approach, the regulatory framework within which HCTs are conducted, and novel CHI applications that would open new translational pathways.
For further information please contact:
Project Director - Infectious Diseases & Viral Challenge Unit
Generaal De Wittelaan 19A Bus 5
B - 2800 Mechelen – Belgium
t: +44 (0)78943 92625